AAAAAA
Results:
1-10
|
Results: 10
Authors:
Del Mastro, L
Venturini, M
Viscoli, C
Bergaglio, M
Signorini, A
Bighin, C
Bertell, G
Semino, C
Pietra, G
Bertoglio, S
Sertoli, MR
Lambiase, A
Rosso, R
Melioli, G
Citation: L. Del Mastro et al., Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients, ANN ONCOL, 12(4), 2001, pp. 505-508
Authors:
Santini, G
Nati, S
Spriano, M
Gallamini, A
Pierluigi, D
Congiu, AM
Truini, M
Rubagotti, A
Chisesi, T
Vimercati, R
Rossi, E
Sertoli, MR
Mattei, D
Marino, G
Gobbi, M
Citation: G. Santini et al., Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma, HAEMATOLOG, 86(3), 2001, pp. 282-286
Authors:
Bajetta, E
Del Vecchio, M
Vitali, M
Martinetti, A
Ferrari, L
Queirolo, P
Sertoli, MR
Cainelli, T
Cellerino, R
Cascinelli, N
Citation: E. Bajetta et al., A feasibility study using polychemotherapy (cisplatin plus vindesine plus dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma, TUMORI, 87(4), 2001, pp. 219-222
Authors:
Pronzato, P
Queirolo, P
Vecchio, S
Lionetto, R
Del Mastro, L
Venturini, M
Gardin, G
Alama, A
Sertoli, MR
Citation: P. Pronzato et al., Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy, ONCOL-BASEL, 60(1), 2001, pp. 88-93
Authors:
Banfi, A
Podesta, M
Fazzuoli, L
Sertoli, MR
Venturini, M
Santini, G
Cancedda, R
Quarto, R
Citation: A. Banfi et al., High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors - A mechanism for post-bone marrow transplantation osteopenia, CANCER, 92(9), 2001, pp. 2419-2428
Authors:
Santini, G
Coser, P
Congiu, AM
Salvagno, L
De Souza, C
Sertoli, MR
Olivieri, A
Chisesi, T
Rubagotti, A
Truini, M
Contu, A
Porcellini, A
Zambaldi, G
Nati, S
Marino, G
Rizzoli, V
Citation: G. Santini et al., VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group, HAEMATOLOG, 85(2), 2000, pp. 160-166
Authors:
Ribizzi, I
Darnowski, JW
Goulette, FA
Sertoli, MR
Calabresi, P
Citation: I. Ribizzi et al., Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line, LEUK RES, 24(6), 2000, pp. 519-525
Authors:
Queirolo, P
Ponte, M
Gipponi, M
Cafiero, F
Peressini, A
Semino, C
Pietra, G
Lionetto, R
Vecchio, S
Ribizzi, I
Melioli, G
Sertoli, MR
Citation: P. Queirolo et al., Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: A phase III pilot trial, ANN SURG O, 6(3), 1999, pp. 272-278
Authors:
Santini, G
De Souza, C
Congiu, AM
Nati, S
Marino, G
Soracco, M
Sertoli, MR
Rubagotti, A
Spriano, M
Vassallo, F
Rossi, E
Vimercati, R
Piaggio, G
Figari, O
Benvenuto, F
Abate, M
Truini, M
Ravetti, JL
Ribizzi, I
Damasio, E
Citation: G. Santini et al., High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow, LEUK LYMPH, 33(3-4), 1999, pp. 321-330
Authors:
Semino, C
Martini, L
Queirolo, P
Cangemi, G
Costa, R
Alloisio, A
Ferlazzo, G
Sertoli, MR
Reali, UM
Ratto, GB
Melioli, G
Citation: C. Semino et al., Adoptive immunotherapy of advanced solid tumors: An eight year clinical experience, ANTICANC R, 19(6C), 1999, pp. 5645-5649
Risultati:
1-10
|